Fenbendazol e câncer avançado: três casos e a necessidade de estudos

This is a huge study. This is three, three stage four cancer patients, melanoma, uh, breast cancer, and prostate cancer.

Uh, these three advanced cancer patients experienced remission, in two cases complete remission, in one case near remission, um, for an extended period of time, years after initiating this fenbendazole protocol.

Um, and none of them received chemo either, right? So this was with... It wasn't combination.

A few were with a surgery. Um, some did receive, you know, a brief dose of radiation.

But in general, this fenbendazole was linked to extraordinarily, you know, accelerated tumor reductions, um, in a pretty short period of time with extended survival outcomes with, um, no evidence of disease.

And so this is absolutely huge, right? And this, this corroborates, um, the preclinical data, right?

So when they were testing this in animals, they found so many different anti-cancer mechanisms.

And so now we see in humans for the, basically the first time that this does appear to have real anti-tumor effects clinically.

And it is an anti-parasitic like ivermectin, and so we see, we see the same things as well with ivermectin.

Usually, sometimes these doctors pair ivermectin with fenbendazole.

And so this is very promising. What we do really need now though, before we can make claims that it's curing cancer, we need large-scale clinical trials immediately.

As this cancer epidemic increases, it's time for proper study of these extremely safe and cheap compounds.